FDA reports lack of interest, high rejection rate for its STAR program
Regulatory NewsJoanne S. Eglovitch
Biologics License Application (BLA)Biologics/ biosimilars/ vaccinesNew Drug Application (NDA)PharmaceuticalsProduct developmentRegulatory Intelligence/PolicySubmission and registrationUnited StatesUS Food and Drug Administration (FDA)